Oct 20, 2025 8:34pm EDT XORTX Issues Correction Notice and XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency
Oct 20, 2025 6:45pm EDT XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Oct 17, 2025 7:00am EDT XORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems
Sep 04, 2025 7:00am EDT Join XORTX for an Exclusive Live Investor Webinar and Q&A Session on September 10